Pfizer Inc
An insider at 3 companies in coverage, as reported on Form 4. SEC CIK 78003. Latest Form 4 filed Dec 22, 2020.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| BioAtla, Inc.BCAB | 10% owner | 2 | 2020-12-18 | 2020-12-18 |
| Enliven Therapeutics, Inc.ELVN | 10% owner | 7 | 2020-03-16 | 2020-03-16 |
| Allogene Therapeutics, Inc.ALLO | 10% owner | 3 | 2018-10-15 | 2018-10-15 |
Transactions: 12
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2020-12-18 | BioAtla, Inc.10% owner | ConversionSeries D Convertible Preferred Stock | 2,238,090 | not reported | not reported | Form 4 |
| 2020-12-18 | BioAtla, Inc.10% owner | Conversion | 2,238,090 | not reported | not reported | Form 4 |
| 2020-03-16 | Enliven Therapeutics, Inc.10% owner | ConversionSeries B Preferred Stock | 1,894,444 | $0.00 | $0 | Form 4 |
| 2020-03-16 | Enliven Therapeutics, Inc.10% owner | ConversionSeries A Preferred Stock | 5,470,492 | $0.00 | $0 | Form 4 |
| 2020-03-16 | Enliven Therapeutics, Inc.10% owner | ConversionSeries Seed Preferred Stock | 478,749 | $0.00 | $0 | Form 4 |
| 2020-03-16 | Enliven Therapeutics, Inc.10% owner | Purchase | 312,500 | $16.00 | $5.0m | Form 4 |
| 2020-03-16 | Enliven Therapeutics, Inc.10% owner | Conversion | 300,752 | not reported | not reported | Form 4 |
| 2020-03-16 | Enliven Therapeutics, Inc.10% owner | Conversion | 868,467 | not reported | not reported | Form 4 |
| 2020-03-16 | Enliven Therapeutics, Inc.10% owner | Conversion | 76,003 | not reported | not reported | Form 4 |
| 2018-10-15 | Allogene Therapeutics, Inc.10% owner | ConversionSeries A-1 Convertible Preferred Stock | 4,185,997 | $0.00 | $0 | Form 4 |
| 2018-10-15 | Allogene Therapeutics, Inc.10% owner | Purchase | 55,556 | $18.00 | $1.0m | Form 4 |
| 2018-10-15 | Allogene Therapeutics, Inc.10% owner | Conversion | 21,976,484 | not reported | not reported | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 03:51 ET. Listed shows no prices and gives no investment advice.